Weight loss typically follows a predictable pattern : most rapid during the first 36 months, then continuing at a slower rate before plateauing after 1218 months
Vomiting occurs less frequently than nausea but can be problematic when it does occur, particularly if it leads to dehydration or interferes with nutrition and medication absorption
As long as the normal feeding and fasting cycles are maintained, our cells are functionally responsive to insulin. The trouble is when cells develop insulin resistance
Tirzepatide: GI side effects common but well-characterized
- ( About Medications such as semaglutide and other Glucagon-like Peptide-1 receptor agonists (GLP-1 agonists) represent a beacon of hope not just for overweight diabetic patients, but also for those who are generally overweight or obese
What This Means for Patients The results of clinical trials suggest that: Body aches are not among the most common side effects of tirzepatide, but they can occur